renzapride has been researched along with ketanserin in 4 studies
Studies (renzapride) | Trials (renzapride) | Recent Studies (post-2010) (renzapride) | Studies (ketanserin) | Trials (ketanserin) | Recent Studies (post-2010) (ketanserin) |
---|---|---|---|---|---|
70 | 12 | 2 | 3,094 | 335 | 283 |
Protein | Taxonomy | renzapride (IC50) | ketanserin (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0016 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0021 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.265 | |
5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 6.5 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0184 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0027 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0016 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.29 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 1.8 | |
Synaptic vesicular amine transporter | Homo sapiens (human) | 0.18 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.001 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hansen, MB; Skadhauge, E | 1 |
Beubler, E; Hansen, MB; Skadhauge, E; Thørboll, JE | 1 |
Hansen, MB; Jaffe, BM | 1 |
Ito, H; Kamato, T; Miyata, K; Nagakura, Y; Nishida, A; Yamano, M | 1 |
4 other study(ies) available for renzapride and ketanserin
Article | Year |
---|---|
Ketanserin and granisetron reduce cholera toxin-induced hypersecretion in pig jejunum.
Topics: Animals; Animals, Newborn; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cholera Toxin; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Granisetron; Indoles; Intestinal Secretions; Jejunum; Ketanserin; Methysergide; Serotonin Antagonists; Swine; Tropisetron | 1994 |
Effect of indomethacin, renzapride, methysergide, ketanserin, granisetron and citalopram on serotonin-induced fluid accumulation in pig jejunum.
Topics: Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Citalopram; Dose-Response Relationship, Drug; Granisetron; Indomethacin; Intestinal Absorption; Jejunum; Ketanserin; Methysergide; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Swine | 1994 |
5-HT receptor subtypes involved in luminal serotonin-induced secretion in rat intestine in vivo.
Topics: 5-Methoxytryptamine; Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisapride; Ileum; Indoles; Jejunum; Ketanserin; Male; Methysergide; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Tropisetron; Water-Electrolyte Balance | 1994 |
Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
Topics: 4-Aminobenzoic Acid; Animals; Benzamides; Benzimidazoles; Biguanides; Bridged Bicyclo Compounds, Heterocyclic; Colon; Dogs; Dose-Response Relationship, Drug; Gastrointestinal Motility; Hexamethonium; Injections, Intravenous; Ketanserin; Male; Methysergide; Muscle Contraction; Muscle, Smooth; para-Aminobenzoates; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Transducers | 1996 |